MDAI: the cashflow

MyFinsight

For the quarter ending 2025-09-30, MDAI had -$29K decrease in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-3,552	-5,071
Depreciation expense	30	12
Amortization of debt issuance costs	163	120
Stock-based compensation	261	611
Amortization of right-of-use assets	141	280
Cost from issuance of common stock	-	0
Change in fair value of warrant liabilities	-264	1,196
Change in fair value of notes payable	0	220
Issuances of shares for borrowing related costs	0	-241
Accounts receivable	-477	-1,038
Unbilled revenue	-	0
Inventory	-8	37
Prepaid expenses	-228	-355
Other assets	204	-132
Accounts payable	552	-2,049
Accrued expenses	-72	-663
Deferred revenue	-185	-536
Lease liabilities	-84	-276
Net cash used in operating activities	-2,501	-4,867
Proceeds from notes payable - related party	-	0
Proceeds from issuance of common stock and warrants, net of issuance costs	0	3,080
Proceeds from notes payable, net of borrowing costs	0	8,260
Payments for notes payable	62	1,313
Proceeds from warrant exercises	1,992	-
Stock option exercises	555	158
Net cash provided by financing activities	2,485	10,185
Effect of exchange rate changes on cash	-13	49
Net increase/(decrease) in cash	-29	5,367
Cash and cash equivalents at beginning of period	5,157	-
Cash and cash equivalents at end of period	10,495	-

Unit: Thousand (K) dollars